Technical Analysis for CRVS - Corvus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 3.45 0.00% 0.00
CRVS closed down 5.74 percent on Friday, May 29, 2020, on 1.35 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down
Historical CRVS trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
20 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion -5.74%
Pocket Pivot Bullish Swing Setup -14.81%
Doji - Bearish? Reversal -14.81%
Wide Bands Range Expansion -14.81%
Wide Bands Range Expansion -6.76%
200 DMA Support Bullish -13.10%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies that are designed to harness the immune system to attack cancer cells. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that plan to initiate a Phase 1/1b clinical trial for adenosine, an immune checkpoint. The company also develops a product candidate, an anti-CD73 monoclonal antibody that inhibits the production of adenosine. Corvus Pharmaceuticals, Inc. was founded in 2014 and is based in Burlingame, California.
Biotechnology Biopharmaceutical Medical Specialties Life Sciences Immunology Immune System Cancer Immunotherapy Monoclonal Antibody Immune Checkpoint Oncology Therapies

Is CRVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.1
52 Week Low 1.01
Average Volume 131,101
200-Day Moving Average 3.56
50-Day Moving Average 2.75
20-Day Moving Average 3.40
10-Day Moving Average 3.66
Average True Range 0.39
ADX 30.87
+DI 22.32
-DI 17.98
Chandelier Exit (Long, 3 ATRs ) 3.05
Chandelier Exit (Short, 3 ATRs ) 3.29
Upper Bollinger Band 4.27
Lower Bollinger Band 2.53
Percent B (%b) 0.53
BandWidth 51.22
MACD Line 0.27
MACD Signal Line 0.28
MACD Histogram -0.008
Fundamentals Value
Market Cap 72.22 Million
Num Shares 20.9 Million
EPS -2.58
Price-to-Earnings (P/E) Ratio -1.34
Price-to-Sales 0.00
Price-to-Book 2.78
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.07
Resistance 3 (R3) 4.07 3.87 3.96
Resistance 2 (R2) 3.87 3.71 3.87 3.93
Resistance 1 (R1) 3.66 3.62 3.56 3.66 3.89
Pivot Point 3.46 3.46 3.41 3.46 3.46
Support 1 (S1) 3.25 3.30 3.15 3.25 3.01
Support 2 (S2) 3.05 3.21 3.05 2.97
Support 3 (S3) 2.84 3.05 2.94
Support 4 (S4) 2.84